TR200908308A1 - Etodolak içeren sürekli salım tablet formulasyonu - Google Patents

Etodolak içeren sürekli salım tablet formulasyonu

Info

Publication number
TR200908308A1
TR200908308A1 TR2009/08308A TR200908308A TR200908308A1 TR 200908308 A1 TR200908308 A1 TR 200908308A1 TR 2009/08308 A TR2009/08308 A TR 2009/08308A TR 200908308 A TR200908308 A TR 200908308A TR 200908308 A1 TR200908308 A1 TR 200908308A1
Authority
TR
Turkey
Prior art keywords
sustained
formulation containing
release tablet
tablet formulation
etodolac
Prior art date
Application number
TR2009/08308A
Other languages
English (en)
Inventor
Gülhan Pi̇lli̇ Hati̇ce
Yi̇ği̇t Ari̇f
Deni̇z Hi̇lmi̇
Faruk Firat Ömer
Original Assignee
Turgut İlaçlari A.Ş.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Turgut İlaçlari A.Ş. filed Critical Turgut İlaçlari A.Ş.
Priority to TR2009/08308A priority Critical patent/TR200908308A1/tr
Priority to PCT/TR2010/000216 priority patent/WO2011087464A1/en
Priority to EP10798647.3A priority patent/EP2525785B1/en
Publication of TR200908308A1 publication Critical patent/TR200908308A1/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Bu buluş, prostaglandin biyosentezini inhibe ederek; osteoartrit, romatoid artrit ve ankilozan spondilit belirti ve bulgularının tedavisinde, akut gut artriti, akut kas iskelet sistemi ağrıları, post operatif ağrı ve dismenore tedavisinde etkili bir non-steroid antienflamatuvar olan, 2-(1,8-dietil-4,9-dihidro-3H-pirano[3,4-b]indol 1-il)asetik asit (Etodolak) içeren, sürekli salım formunda formulasyon hazırlama metodu ile ilgilidir.
TR2009/08308A 2010-01-18 2010-01-18 Etodolak içeren sürekli salım tablet formulasyonu TR200908308A1 (tr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
TR2009/08308A TR200908308A1 (tr) 2010-01-18 2010-01-18 Etodolak içeren sürekli salım tablet formulasyonu
PCT/TR2010/000216 WO2011087464A1 (en) 2010-01-18 2010-11-01 Sustained release tablet formulation containing etodolac
EP10798647.3A EP2525785B1 (en) 2010-01-18 2010-11-01 Sustained release tablet formulation containing etodolac

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2009/08308A TR200908308A1 (tr) 2010-01-18 2010-01-18 Etodolak içeren sürekli salım tablet formulasyonu

Publications (1)

Publication Number Publication Date
TR200908308A1 true TR200908308A1 (tr) 2011-08-22

Family

ID=43969399

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2009/08308A TR200908308A1 (tr) 2010-01-18 2010-01-18 Etodolak içeren sürekli salım tablet formulasyonu

Country Status (3)

Country Link
EP (1) EP2525785B1 (tr)
TR (1) TR200908308A1 (tr)
WO (1) WO2011087464A1 (tr)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4657757A (en) * 1985-03-29 1987-04-14 Schering Corporation Controlled release dosage form comprising acetaminophen, pseudoephedrine sulfate and dexbrompheniramine maleate
US4704285A (en) 1985-11-18 1987-11-03 The Dow Chemical Company Sustained release compositions comprising hydroxypropyl cellulose ethers
IE60311B1 (en) 1987-09-24 1994-06-29 American Home Prod Sustained release etodolac
AU9062998A (en) 1997-09-11 1999-03-29 Nycomed Danmark A/S Modified release multiple-units compositions of non-steroid anti-inflammatory drug substances (nsaids)
US6106862A (en) * 1998-08-13 2000-08-22 Andrx Corporation Once daily analgesic tablet
AU6589200A (en) 1999-09-10 2001-04-17 Ranbaxy Laboratories Limited Extended release formulation of etodolac

Also Published As

Publication number Publication date
WO2011087464A1 (en) 2011-07-21
EP2525785A1 (en) 2012-11-28
EP2525785B1 (en) 2015-03-25

Similar Documents

Publication Publication Date Title
NO20064893L (no) Syntese av boronsyre-estere og -syreforbindelser
JO3131B1 (ar) مركبات كيميائية
EA201300282A1 (ru) Производные триазолопиразина
UA108240C2 (uk) Похідні гексафторізопропілкарбамату, їх одержання і їх терапевтичне застосування
CY1111269T1 (el) Ρυθμιστες βενζιμιδαζολης του vr1
BR112015000579A2 (pt) tioxantonas polimerizáveis
CL2009000503A1 (es) Proceso de preparacion de compuestos derivados de acido 2-amino-5-cianobenzoico-3-sustituidos o 1h-pirazol-5-carboxamida.
MY176420A (en) Triazolone compounds as mpges-1 inhibitors
EA201300730A1 (ru) Производные индазолилтриазола
EA201300283A1 (ru) Производные фуропиридина
EA200901563A1 (ru) Новый способ синтеза ивабрадина и его солей присоединения с фармацевтически приемлемой кислотой
UY32423A (es) Derivados de azaspiranil-alquilcarbamatos de 5 eslabones, su preparacion y su aplicacion en terapeutica
EA200900945A1 (ru) Новый способ синтеза агомелатина
EA201491658A1 (ru) Таблетки для комбинированной терапии
EP2516624A4 (en) CELL LINE 3M
NI201100149A (es) Derivados de tiadiazoles y oxadiazoles, su preparación y su aplicación en terapia.
BR112013018751A2 (pt) método de cultura de célula animal
MX2017005423A (es) Inhibidores de histona desacetilasa y sus usos en terapia.
EA201001087A1 (ru) Новые дигидроиндолоновые соединения, способ их получения и фармацевтические композиции, содержащие их
EA201101147A1 (ru) Новый способ синтеза ивабрадина и его солей присоединения с фармацевтически приемлемой кислотой
EA201201667A1 (ru) Способ получения l-аргининовой соли периндоприла
CY1121055T1 (el) Μεθοδος για την παρασκευη φορτισμενων διασυνδετων
EA200901377A1 (ru) Соединения из ряда амидов нафталинкарбоновой и изохинолинкарбоновой кислот и их применение
UA103290C2 (ru) Фармацевтическая композиция ибупрофена для инъекции
EA201200123A1 (ru) Новый способ синтеза ивабрадина и его фармацевтически приемлемых кислотно-аддитивных солей